论文信息 - Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study - 字舞流文

Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study

N. Taira | H. Iwata | Y. Ohashi | H. Bailey | H. Sasano | N. Masuda | Y. Shibahara | T. Toyama | S. Ohtani | Takuhiro Yamaguchi | C. Chao | D. Cherbavaz | K. Sakamaki | Yutaka Yamamoto | M. Kashiwaba | Takehiko Sakai | T. Fujisawa | R. Nakamura | Y. Hasegawa | H. Akabane | D. Jakubowski | N. Sugiyama